Literature DB >> 30037754

Antiprotozoal and cysteine proteases inhibitory activity of dipeptidyl enoates.

Santiago Royo1, Tanja Schirmeister2, Marcel Kaiser3, Sascha Jung2, Santiago Rodríguez1, José Manuel Bautista4, Florenci V González5.   

Abstract

A family of dipeptidyl enoates has been prepared and tested against the parasitic cysteine proteases rhodesain, cruzain and falcipain-2 related to sleeping sickness, Chagas disease and malaria, respectively. They have also been tested against human cathepsins B and L1 for selectivity. Dipeptidyl enoates resulted to be irreversible inhibitors of these enzymes. Some of the members of the family are very potent inhibitors of parasitic cysteine proteases displaying k2nd (M-1s-1) values of seven orders of magnitude. In vivo antiprotozoal testing was also performed. Inhibitors exhibited IC50 values in the micromolar range against Plasmodium falciparum, Trypanosoma brucei, Trypanosoma cruzi and even more promising lower values against Leishmania donovanii.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chagas disease; Cysteine proteases; Inhibitors; Malaria; Sleeping sickness

Mesh:

Substances:

Year:  2018        PMID: 30037754     DOI: 10.1016/j.bmc.2018.07.015

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

1.  Benzimidazole inhibitors of the major cysteine protease of Trypanosoma brucei.

Authors:  Glaécia An Pereira; Lucianna H Santos; Steven C Wang; Luan C Martins; Filipe S Villela; Weiting Liao; Marco A Dessoy; Luiz C Dias; Adriano D Andricopulo; Mariana Af Costa; Ronaldo Ap Nagem; Conor R Caffrey; Klaus R Liedl; Ernesto R Caffarena; Rafaela S Ferreira
Journal:  Future Med Chem       Date:  2019-07       Impact factor: 3.808

2.  Development of Reduced Peptide Bond Pseudopeptide Michael Acceptors for the Treatment of Human African Trypanosomiasis.

Authors:  Santo Previti; Roberta Ettari; Carla Di Chio; Rahul Ravichandran; Marta Bogacz; Ute A Hellmich; Tanja Schirmeister; Sandro Cosconati; Maria Zappalà
Journal:  Molecules       Date:  2022-06-11       Impact factor: 4.927

3.  The complex of Plasmodium falciparum falcipain-2 protease with an (E)-chalcone-based inhibitor highlights a novel, small, molecule-binding site.

Authors:  Jonathan M Machin; Anastassia L Kantsadi; Ioannis Vakonakis
Journal:  Malar J       Date:  2019-12-02       Impact factor: 2.979

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.